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Abstract. The liver is important in the biotransformation of various drugs, where hepatic transporters facilitate
uptake and excretion. Ischemia-reperfusion (I/R) injury is a common occurrence in liver surgery, and the developing
oxidative stress can lead to graft failure. We used intravital multiphoton tomography, with fluorescence lifetime
imaging, to characterize metabolic damage associated with hepatic I/R injury and to model the distribution of
fluorescein as a measure of liver function. In addition to measuring a significant increase in serum alanine trans-
aminase levels, characteristic of hepatic I/R injury, a decrease in the averaged weighted lifetime of reduced nico-
tinamide adenine dinucleotide phosphate was observed, which can be attributed to a changed metabolic redox
state of the hepatocytes. I/R injury was associated with delayed uptake and excretion of fluorescein and elevated
area-under-the-curve within the hepatocytes compared to sham (i.e., untreated control) as visualized and modeled
using images recorded by intravital multiphoton tomography. High-performance liquid chromatography analysis
showed no differences in plasma or bile concentrations of fluorescein. Finally, altered fluorescein distribution was
associated with acute changes in the expression of liver transport proteins. In summary, multiphoton intravital im-
aging is an effective approach to measure liver function and is more sensitive in contrasting the impact of I/R injury
than measuring plasma and bile concentrations of fluorescein. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)
[DOI: 10.1117/1.JBO.18.10.101306]
Keywords: multiphoton microscopy; intravital imaging; ischemia-reperfusion injury; biliary excretion; drug transport; real-time polymer-
ase chain reaction; western blot; high-performance liquid chromatography.
Paper 12829SSRR receivedDec. 28, 2012; revisedmanuscript receivedMay 23, 2013; accepted for publicationMay 23, 2013; published
online Jun. 28, 2013.
1 Introduction
A growing interest in intravital imaging has evolved due to lim-
itations of conventional techniques in measuring dynamic real-
time events.1 Intravital microscopy provides information about
molecular and cellular processes with high spatial and temporal
resolution in vivo.2 Imaging of live animal organs has been going
on for 80 years, but has largely increased in the last decade with
the improvement of conventional microscopes, especially non-
linear excitation, which has allowed deep tissue imaging.3
Multiphoton tomography (MPT) is the most popular appli-
cation of fluorescence microscopy for imaging thick tissue and
live animals, producing high-resolution three-dimensional
images.4 It involves the excitation of two (or more) photons
of lesser energy normally produced by single photon absorption
of higher energy.5 MPT is particularly well suited for in vivo
studies of drug distribution in biological tissues, as it reduces
tissue damage and enhances image quality due to reduced pho-
tobleaching and increased penetration depth compared with
conventional fluorescence microscopy.6–8 Fluorescence lifetime
imaging microscopy (FLIM) in combination with MPT can
identify fluorescent probes with overlapping spectral properties
and measure lifetime specific for the probe and the surrounding
environment.9 For example, autofluorescent nicotinamide
adenine dinucleotide (NADH) is a direct measure of cellular
metabolic state and can be used to study cellular damage.10–12
The free and bound forms of NADH are involved in the anaero-
bic and aerobic production of adenosine triphosphate (ATP),
respectively.13,14 Accordingly, a change in the free/bound ratio
gives insight into the metabolic state of a cell. In a previous
study, our group showed a decreased metabolic activity as
shown by an increased ratio of free/bound NADH in ischemia-
reperfusion (I/R) injury in the liver.12
I/R injury is a common phenomenon in liver transplantation
and resection, with morbidity and mortality as complica-
tions.15,16 During liver transplantation, ischemic damage occurs
when blood flow is cut off to the donating liver, and the injury is
further intensified when the liver is transplanted into the recipi-
ent.17 The reason for reperfusion injury is the reintroduction of
oxygenated blood, which results in oxidative stress, causing
increased microvascular permeability, intracellular ATP loss,
inflammatory cell infiltration, and, potentially, cell death.18–20
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As a consequence, oxidative stress may lead to graft failure and
rejection of the liver.21 Cellular damage occurring in I/R injury
have been shown to affect membrane proteins,22–24 which
could affect distribution of drugs in the liver.
Hepatic transporters are membrane proteins located on the
sinusoidal, lateral, or canalicular membranes, facilitating uptake
and excretion of many endogenous and exogenous substances.25
Fluorescein is a fluorescent probe and a substrate for the uptake
transporters organic anion transporting polypeptides (OATP).26
It is metabolized to fluorescein monoglucuronide.27 Both fluo-
rescein and fluorescein monoglucuronide are excreted into the
bile by multidrug resistance-associated protein 2 (MRP2). It is
not known if they are substrates for MRP3,28 an export trans-
porter located on the lateral membrane of the cell, transporting
substrate back to the blood (Fig. 1).25 However, other members
of the fluorescein family, such as 5(6)-carboxy-2’7’-dichloro-
fluorescein and 5(6)-carboxyfluorescein, are secreted into the
blood by MRP3; thus, it is likely that fluorescein and fluorescein
monoglucuronide also interact with this transporter.29,30
The aim of this study was to investigate the transport of
fluorescein in the liver following I/R injury by intravital multi-
photon tomography, correlating these results with changes in
biliary excretion, plasma concentrations, and expression of the
transporters.
2 Materials and Methods
2.1 Chemicals and Reagents
Sodium fluorescein and β-glucuronidase were purchased from
SigmaAldrich (St.Louis,MO). Iliumxylazil andketaminehydro-
chloride were obtained from Bayer Australia (Pymble NSW,
Australia) and Parnell Laboratories, Australia, respectively.
Reagents used for western blot analysis were purchased from
Bio-rad (Protein std precision plusBIO-Rad, IMMuno-blotmem-
brane PVDF, 10× TGS Buffer, 10× TG Buffer, 30%
Acrylamide/Bis Solution, 29∶1, TEMED and Ammonium
Persulfate); Thermo Fisher (Supersensitive West Femto Maxi-
mum Sensitivity, Pierce BCA Protein Assay Kit, Dental
Developer replenisher, Dental fixer replenisher and T-mat g
film); and Whatman (Whatman filter paper). MRP2 monoclonal
[M2 III-6] antibody (catalogue number AB3373) was purchased
from Sapphire Bioscience (Sydney NSW, Australia); OATP2
(catalogue number AB3572P) was purchased from Merck
Millipore (Kilsyth VIC, Australia); and rabbit antibody MRP3
from Sigma Aldrich. The reagents used in real-time polymerase
chain reaction (RT-PCR) were obtained from Invitrogen to Life
Technologies Australia (Mulgrave, Victoria, Australia) (Sybr
master mix) and Sigma Aldrich [quantitative PCR (qPCR)
primers].
2.2 Animals
Male Wistar rats, weighing 320 20 g, purchased from the
University of Queensland Biological Resources, were used in
all experiments. All studies were approved by the Animal
Ethics Committee at the University of Queensland. Rats were
housed at the University of Queensland in Pharmacy Australia
Centre of Excellence, where the temperature was maintained at
20 1°C and humidity at 60 to 75%, with artificial light for 12 h
(7 a.m. to 7 p.m.) daily. All animals had unlimited access to food
and water.
2.3 Surgical Procedures and I/R Model
Rats were anaesthetized initially by an intraperitoneal injec-
tion of ketamine hydrochloride (80 mg∕kg) and xylazine
(10 mg∕kg). Anesthesia was maintained throughout the experi-
ment by administering ketamine (2.2 mg∕100g) and xylazil
(0.25 mg∕100g). Body temperature was controlled by placing
rats on a heating pad set to 37°C. Ischemia was induced locally
in approximately 70% of the liver, by clamping the portal vein,
hepatic artery, and bile duct supplying the median and left lobes
using a microvascular clamp. After 60 min, the clamp was
removed to allow reperfusion of the liver for 4 h and rats
were allowed to recover during this time under close monitoring.
Sham rats (i.e., untreated controls) underwent the same pro-
cedure without clamping the vessels. After 3 h of reperfusion,
rats were again anaesthetized. The jugular vein and carotid
artery were cleared of surrounding tissue and cannulated using
polyethylene (PE)-tubing for administration of sodium fluores-
cein (intravenous bolus 10 mg∕kg at 4 h of reperfusion) and
blood collection. A midline laparotomy was performed to
expose the liver and to cannulate the bile duct, which was
cleared of surrounding fat tissue and cannulated using PE-tub-
ing. The left lobe was slightly raised above the intraperitoneal
cavity to allow imaging of fluorescein distribution. The liver and
intraperitoneal cavity were kept moist by continuous adminis-
tration of 0.9% saline throughout the experiment.
2.4 Tissue Collection
Blood (0.2 mL) was collected during the surgery from the
inferior vena cava using a 30 gauge needle and plasma concen-
tration of alanine transaminase (ALT) was measured using a
Hitachi 747 analyzer (Hitachi Ltd., Tokyo, Japan). Blood for
fluorescein determination was collected at 5, 10, 30, 60, 120,
and 180 min from the carotid artery. Bile was collected in pre-
weighted tubes every 10 min for 1 h and every hour after that for
3 h. At the end of the experiment, the left and median lobes were
excised and portions were snap frozen in liquid nitrogen and
stored at −70°C for later analysis with western blot and RT-PCR.
2.5 Multiphoton Intravital Imaging
MPT images were recorded using a DermaInspect system
(JenLab GmbH, Jena, Germany) equipped with an ultrashort
(85 fs pulse width) pulsed mode-locked 80-MHz Titanium:
Sapphire MaiTai laser (Spectra Physics, 25 Mountain View,
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Fig. 1 Schematic overview of fluorescein uptake and distribution in the
liver.
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USA). The excitation wavelength was set to 740 nm for liver
autofluorescence and 920 nm for fluorescein fluorescence,
with an emission signal range of 350 to 650 nm established
through the use of a BG39 bandpass filter. Images were recorded
with 10× (low magnification) or 40× (high magnification)
objectives. The laser power was set to 15 or 20 mW and the
acquisition time for obtaining the images was 13.4 or 7.4 s
per frame for high- and low-magnification imaging, respec-
tively. Each image was 179 × 179 μm wide at a resolution of
512 × 512 pixels. The left lobe of the liver was placed on a
metal plate, attached to an adjustable stand that could be
elevated or lowered as required. The plate was slightly raised
above the intraperitoneal cavity to reduce movement in the
image from respiration and to minimize pressure on the organs
underneath. Images were recorded before injection of fluores-
cein and then continuously throughout the experiment up to
180 min.
FLIM data were collected with a time-correlated single-pho-
ton counting (TCSPC) SPC-830 detector (Becker & Hickl
GmbH, Berlin, Germany) integrated into the MPT system.
The TCSPC module assembles a photon distribution of the scan
area across the x and y coordinates taken from four photon coun-
ters, with only three used for this study. The module determines
the time of arrival for each photon detected within the fluores-
cence decay. Fluorescence emission was spectrally resolved
between three linearly arranged photon counters through the
use of three dichroic filters in the beam path, spectrally dividing
the emission light into three channels for each photon counter:
350 to 450 nm {reduced nicotinamide adenine dinucleotide
phosphate [NAD(P)H]}, 450 to 515 nm [NAD(P)H, flavin
adenine dinucleotide (FAD)], and 515 to 620 nm (FAD, fluores-
cein).10,31 Each FLIM image was collected at an exposure of
13.4 s and acquisition image size of 214 × 214 μm.
2.6 Image Processing
All image processing was done in ImageJ 1.44p (National
Institutes of Health, USA). To trace the distribution of fluores-
cein in blood and hepatocytes, these areas were selected in the
images recorded by low magnification. For analysis of fluores-
cein distribution in bile, this area was selected in images
recorded by high magnification. The mean fluorescence inten-
sity in these areas was calculated and converted into concentra-
tions using a standard curve prepared in homogenized liver. The
profile of fluorescein concentration (in sinusoid or hepatocyte)
versus time was fitted by an empirical triexponential model.
C ¼ A1e−B1×t þ A2e−B2×t þ A3e−B3×t; (1)
where C is the concentration of F, t is the time, A1, A2, A3, B1,
B2, B3 are model parameters, and t1∕2 was calculated as
0.693∕B3. The area under the curve (AUC) was calculated as
AUC ¼ A1
B1
þ A2
B2
þ A3
B3
. (2)
Model fitting was performed using software SCIENTIST®
(Micromath Scientist, Salt Lake City, UT).
2.7 FLIM Data Analysis
FLIM data analysis was performed using SPCImage 3.9.7 soft-
ware (Becker & Hickl GmbH). FLIM data is composed of an
array of pixels containing several time channels distributed
across the fluorescence decay curve. The decay curve represents
a sum of multiple exponentials, or components, as each pixel
contains an overlay of fluorescence from several endogenous
fluorophores at various conformations. For the data we obtained,
a double-exponential decay model function was used.
fðtÞ ¼ α1e−t∕τ1 þ α2e−t∕τ2 with α1 þ α2 ¼ 1: (3)
The fitted decay curve establishes two lifetimes: the short
(τ1) and long (τ2) fluorescence decay lifetimes (ps) and with
corresponding relative amplitude coefficients α1 and α2 (%),
respectively.
The instrument response function (IRF) was calibrated using a
sucrose crystal standard first analysed by FLIM (Ajax Finechem
Pty Ltd, Sydney, NSW, Australia) was used. Each individual
FLIM image is convoluted with IRFðtÞ in the model function,
fðtÞ, to calculate the function FðtÞ. The function below corre-
sponds to the shape of the signal if the measured optical signal
was identical to the model function fðtÞ.
FðtÞ ¼ fðtÞ  IRFðtÞðrepresents the convolution symbolÞ:
(4)
Using the FðtÞ function, the measured data points are
obtained and analyzed to determine the average lifetime and rel-
ative contributions of each endogenous molecule.
2.8 High-Performance Liquid Chromatography
The concentration of fluorescein and fluorescein monoglucuro-
nide in each collected bile sample was determined by high-
performance liquid chromatography (HPLC, Shimadzu,
Kyoto, Japan) using 1 mL/min flow rate with a C18 column
[Agilent HC-C18 (2) 4.6 × 150 mm, 5 μm] that included a secu-
rity guard column (Phenomex C18 4 × 3 mm). Fluorescence
excitation and emission wavelengths were 488 and 515 nm,
respectively, with a retention time of 5 min. The mobile
phase consisted of 50 mM NaH2PO4 and methanol (2∶3).
Analysis of fluorescein involved diluting 5 μl of bile to
500 μl with 0.2 M acetate buffer. For analysis of fluorescein
monoglucuronide (FG), a 5-μl bile sample was diluted in
50 μl β-glucuronidase (10 U/100 μl). All samples were then
incubated for 1 h at 37°C in a water bath. Fluorescein samples
were further diluted in deionized water (1∶10), whereas FG
samples were first diluted in an acetate buffer (1∶20) and
then in water (1∶10). Samples (10 μl) were injected into the
HPLC system. Bile was collected in preweighted tubes, ena-
bling calculation of the excretion rates for fluorescein and fluo-
rescein monoglucuronide.
2.9 RT-PCR
RNAwas extracted from 100 to 150 mg liver tissue using TRIzol
Reagent as instructed by the manufacturer. DNA contaminations
were removed by incubation with RNase-free DNAse-1. First
strand cDNA was synthesized from 1 μg total RNA using
SuperScript III reverse transcriptase (Invitrogen) and oligo dT
as instructed by the manufacturer.
cDNA was diluted (1∶20) in water, and 2 μl of the sample
was added to each well in duplicates. A mixture containing 5 μl
platinum SYBR® Green qPCR, 0.2 μl of forward and 0.2 μl of
reverse primer and 2.6 μl water, was added to each well, after
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which the plate was centrifuged to mix the solutions. RT-PCR
was read using a Roche LightCycler480.
2.10 Western Blot
Liver slices were homogenized in protein lysis buffer solution
(1∶20, weight:volume), after which triton (10 μL∕ml buffer)
was added and stored on ice. The solution was centrifuged at
13,000 rpm at 4°C for 20 min and the supernatant was collected.
The supernatant, equivalent to 30 or 50 μg of protein, was mixed
with loading buffer and heated for 5 min at 100°C. Acrylamide
resolving gel (10%) and 4% stacking gel, both with sodium
dodecyl sulfate, were prepared with tris-glycine as a running
buffer. Electrophoresis was run at 150 V for 45 min, after
which the gel was transferred to membranes at 100 V for 1 h at
4°C. Themembranes were blocked in 10% skimmilk in blocking
buffer [tris-buffered saline with 0.1% Tween 20 (TBS-T)] over-
night at 4°C while shaking. Membranes were incubated with pri-
mary antibody (1∶500 for OATP2 and MRP2 and
1∶1000 for MRP3) in blocking buffer for 1.5 h, after which it
was washed in TBS-T. Membranes were incubated with the
secondary antibody (1∶100 K for OATP2, 1∶300 K for MRP3,
and 1∶20 K for MRP2) for 1.5 h, followed by washing in TBS-
T first and then TBS. The membrane was developed onto film
using a luminescence kit (SuperSignal®West Femto)with a reac-
tion time of 5 min. β-actin was used as a loading control (1∶1000
for primary and 1∶200 K for secondary antibody). Protein bands
werequantifiedusing ImageJ andadjustedwithdensityofβ-actin.
2.11 Statistical Analysis
The data are expressed as mean standard error of themean
(n ¼ 3 to 7). A student’s t-test was used for statistical compari-
son of serum ALT levels, fluorescence lifetime data, and phar-
macokinetic parameters between sham and I/R injury groups. To
analyze statistical differences in mRNA or protein levels
between sham and I/R injury groups at 4 and 24 h, a one-
way analysis of variance was used with a post hoc Newman-
Keuls test. Statistical analysis was done using GraphPad Prism
v5.03 (GraphPad Software Inc., La Jolla, California) with a
p value less than 0.05 considered statistically significant.
3 Results
3.1 I/R-Induced Elevation in Serum ALT Levels
Figure 2 demonstrates extensive liver damage as indicated by
significantly elevated (p < 0.05; n ¼ 4) serum ALT levels in
rats subjected to I/R injury (1200 260 U∕L) compared to
sham (54 7 U∕L).
3.2 Intravital FLIM Imaging of the Rat Liver after
Sham or I/R Injury
Figure 3(a) shows representative intravital FLIM images (pseu-
docolored according to average weighted lifetime τm), across
three spectral channels (i.e., 350 to 450, 450 to 515, and 515
to 620 nm), of hepatocytes from within the rat liver following
sham or I/R injury. The data demonstrate that in the second spec-
tral channel [450 to 515 nm; NAD(P)H/FAD], τm appears to be
smaller in the rat liver after I/R injury (blue) relative to sham
(yellow-green). This observation is also seen in Fig. 3(b), indi-
cated by the left-shift of the τm histogram derived from the
FLIM image. The average τm [450 to 515 nm; NAD(P)H/FAD]
of hepatocytes from I/R-treated rats (1575.3 41.9 ps) was sig-
nificantly lower (p < 0.001; n ¼ 6) than the sham control
(1225.4 16.3 ps) [Fig. 3(c)]. Further examination revealed
that the fast decay lifetime component (τ1) within hepatocytes
was significantly smaller (p < 0.01) in I/R-treated rats
(1054.5 31.4 ps) compared to the sham control (932.4
17.4 ps) [Fig. 3(d)]. The tendency for the long decay lifetime
component (τ2) in I/R-treated rats to be smaller than the
sham control was not statistically significant. In addition, while
the τm of I/R-treated rats, in the 350 to 450 nm [NAD(P)H] spec-
tral channel appeared smaller than the sham control [Fig. 3(b)],
this difference was not statistically significant.
Similar to Fig. 3, Fig. 4 shows representative redox FLIM
images of hepatocytes from I/R and sham control rats. The
images were pseudocolored according to the ratio of amplitude
coefficients α1 and α2. Figure 4(a) demonstrates that in the
350 to 450 nm [NAD(P)H] spectral channel, the redox ratio
(α1∕α2) appears higher in hepatocytes after I/R injury (red)
relative to sham (blue-green). This tendency is reflected in
the α1∕α2 ratio histograms in Fig. 4(b). However, the average
α1∕α2 ratio in I/R-treated rats (2.663 0.05) is not significantly
higher (p ¼ 0.187) than the sham control (2.501 0.12)
[Fig. 4(c)].
3.3 Fluorescein Uptake, Distribution, and Clearance
from the Rat Liver after I/R Injury
Figure 5 shows representative fluorescence intravital images of
the rat liver, from sham and I/R injury groups, over time after
injection of fluorescein. Representative intravital images, taken
at ×10 and ×40magnifications [Fig. 5(a)], demonstrate elevated
hepatocyte autofluorescence [two photon excitation (2PExc):
740 nm) in the sham control rats compared to I/R injury group.
Figure 5(b) and 5(c) shows representative images of fluorescein
(2PExc: 920 nm) uptake, distribution, and clearance within the
liver of sham and I/R injury rats after injection at selected
time points over a 180-min time-course. Fluorescein was
detected within minutes after injection of fluorescein in sham
and I/R injury rats. Fluorescein appears to be taken up and
cleared from the liver faster in the sham group compared to
the I/R injury group, which displayed delayed uptake and
elevated retention within the liver over time [Fig. 5(b) and 5(c)].
Figure 6(a) to 6(c) show the changes in fluorescein concen-
tration within the sinusoids, hepatocytes, and bile, respectively,
of sham and I/R injury rats after fluorescein injections. It
appears that the fluorescein clearance rate from the sinusoids
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Fig. 2 Alanine transaminase levels in plasma after I/R injury. Values are
presented as mean standard error of themean (SEM) (n ¼ 4 for sham,
n ¼ 6 for I/R injury), * p < 0.05 significantly different from sham.
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was slower for I/R injury, as indicated by a shallower slope
[Fig. 6(a)], which was statistically significant (p < 0.05) at
10 to 25 min. Similarly, the excretion rate from the hepatocytes
also appeared slower in the I/R group [Fig. 6(b)].
Figure 7(a) and 7(b) shows the AUC value and elimination
half-life, respectively, for fluorescein in the sinusoids
and hepatocytes, calculated by fitting data from Fig. 6(a) and
6(b) to a triple exponential equation. The data show a
significantly increased (p < 0.05) AUC in the hepatocytes
(5100 340 μg ⋅min ∕mL) for the I/R injury group compared
to the sham group (2800 640 μg ⋅min ∕mL). The AUC in
the sinusoids and the half-life in the hepatocytes tended to be
higher for the I/R injury group (2030 510 μg ⋅min ∕mL
and 430 61 min, respectively) relative to the sham group
(1200 390 μg ⋅min ∕mL and 250 55 min, respectively),
but these differences were not statistically significant.
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Fig. 3 I/R injury associated changes in the average weighted fluorescence lifetime (τm) within the liver in vivo. (a) Representative τm intravital images of
sham and I/R injury in the liver. FLIM data were measured within three spectral ranges [pseudocolor range (blue-to-red) indicated in parenthesis]: 350
to 450 (750 to 1500 ps), 450 to 515 (1000 to 1750 ps), and 515 to 620 nm (500 to 1750 ps) to capture NAD(P)H, NAD(P)H/FAD, and FAD/fluorescein,
respectively. Each image is 214 × 214 × 1 μm3. (b) τm lifetime histograms of sham and I/R injury liver NAD(P)H, NAD(P)H/FAD, and FAD/fluorescein,
respectively. The histograms represent the average pixel intensity for each τm lifetime. (c) The corresponding average τm lifetimes from the three spectral
channels are charted for the sham and I/R injury groups. (d) The average short (τ1) and long (τ2) decay lifetimes obtained from the NAD(P)H/FAD (450 to
515 nm) channel for the sham and I/R injury groups. Values are presented as the mean±SEM (n ¼ 6),   p < 0.01 or   p < 0.001 significantly different
from sham.
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3.4 Concentration of Fluorescein in Plasma and
Excretion of Fluorescein and Metabolites in Bile
Figure 8(a) demonstrates that the plasma concentration of
fluorescein, measured by HPLC, was similar in sham and I/R
injury groups at 4 h of reperfusion. The biliary excretion rate
of fluorescein [Fig. 8(b)] showed a slight tendency to be
lower in the I/R injury group relative to the sham control
group, though these differences were not statistically significant.
In contrast, the biliary excretion rate of fluorescein monoglucur-
onide for sham and I/R injury groups was comparable over time
[Fig. 8(c)].
3.5 mRNA and Protein Expression of OATP2, MRP2,
and MRP3
Figure 9 shows the mRNA and protein expression of OATP2,
MRP2, and MRP3 within excised liver tissue from sham and
I/R injury groups. mRNA expression of the transporter gene
MRP2 tended to be higher in the I/R injury group compared to
the sham group after 4 h of reperfusion, respectively, while
OATP2 and MRP3 transporter expression appeared to decrease
after 4 and 24 h of reperfusion, respectively [Fig. 9(a)]. How-
ever, none of these differences were statistically significant.
Similar to mRNA expression, OATP2 protein levels for the I/R
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injury group appeared to be higher than the sham group after 4 h of
reperfusion [Fig. 9(b) and 9(c)]. MRP2 protein levels were com-
parable between sham and I/R injury groups at both time points.
After 4 h of reperfusion, MRP3 levels in the I/R injury group were
significantly lower than the sham [Fig. 9(c)]. At 24 h, MRP3
protein levels were comparable to the sham group.
4 Discussion
In this study, we used intravital imaging of the rat liver to further
characterize hepatic metabolic damage associated with I/R
injury. I/R injury was confirmed by measuring elevated serum
ALT levels and changes in the metabolic and redox state of
hepatocytes by FLIM. Intravital imaging of fluorescein uptake,
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Fig. 5 Representative intravital images of fluorescein uptake in the sham and I/R injury rat liver groups. (a) Fluorescence intensity images recorded in
vivo at λExc∕Em: 740∕350 to 650 nm (endogenous autofluorescence) within sham and I/R injury (4 h of reperfusion) groups at low (10×) and high (40×)
magnifications. (b) and (c) Fluorescence intensity images recorded in vivo at λExc∕Em: 920∕350 to 650 nm (fluorescein fluorescence alone) in sham and I/
R injury groups at various time points following 4 h of reperfusion at low (10×) and high (40×) magnifications, respectively. Narrow arrows indicate
blood vessels, filled white arrows show hepatocytes, and opened arrows show bile duct. Scale bars for images taken at 10× and 40× magnifications
indicate a length of 200 and 40 μm, respectively.
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distribution, and clearance was a more sensitive indicator of
impaired liver function for I/R injury than measuring fluorescein
levels in plasma or biliary excretion. Changes in uptake and
clearance were also associated with acute changes in liver trans-
port protein expression.
As with previous studies showing an increased ALT in
response to I/R injury,12,23,32 the present model for I/R injury
also resulted in a significant elevation of serum ALT (Fig. 2),
indicative of liver damage.
We have previously described differences in the redox state
of hepatocytes, using fluorescence lifetime imaging, between
the sham and I/R damaged rat liver.12 Specifically, the amplitude
coefficients ratio (α1∕α2) of the short (τ1) and long (τ2) decay
lifetimes increased over 4 h after I/R injury. The ratio is an
indicator of the redox state of the cells, representing the propor-
tion of free and protein-bound NAD(P)H within the cell.10 While
we observed a tendency for the redox ratio to be elevated, this
difference was not statistically significant (Fig. 4).
In this study, we further characterized changes in the meta-
bolic state of hepatocytes, after I/R injury, identifying a decrease
in average weighted lifetime (τm), specifically due to a decrease
in the τ1 lifetime (Fig. 3). This lifetime difference was observed
in both the 350 to 450 and 450 to 515 nm spectral channels, both
of which encompass NAD(P)H autofluorescence,31 though this
was statistically significant only in the latter. The lack of any
change in the fluorescence lifetime in the 515 to 620 nm spectral
channel, which predominantly isolates the FAD autofluores-
cence,31 further supports the conclusion that NAD(P)H is
responsible for the lifetime changes observed in the 450 to
515 nm channel. Moreover, as no lifetime change was simulta-
neously observed for FAD, this suggests that an environmental
factor (e.g., pH) may not be responsible for the decrease in the τ1
lifetime of NAD(P)H [Fig. 3(d)] and may instead indicate a pro-
tein-binding interaction. As a result, the increase in the α1∕α2
ratio in Fig. 4(b) may not necessarily indicate an increase in
the proportion of free NAD(P)H. Our data are similar to
NAD(P)H τm differences observed between photo-damaged
skin, whereas solar-protected skin had an elevated lifetime
(∼500 ps) compared to solar-exposed skin. This may be due to
similar metabolic damage occurring in both cell types, namely
oxidative damage due to reactive oxygen species generation. As
a result, NAD(P)H may be recruited by similar proteins related
to oxidative repair, causing the lifetime change we observe in
both solar-exposed skin and the liver after I/R injury.33 Interest-
ingly, these lifetime changes are in sharp contrast to ischemic
necrosis and apoptosis, which are associated with a significant
increase in the fluorescence lifetime of NAD(P)H.11,34,35 While
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these processes also involve oxidative damage, the outcome is
ultimately cell death and a breakdown of internal compartmen-
talization within the cell,36 which may alter protein recruitment
of NAD(P)H and thus result in the lifetime changes we observe.
Further studies are required to identify the protein-binding asso-
ciated changes for NAD(P)H in response to I/R injury and cell
death. To our knowledge, we are the first to associate hepatic
I/R injury with specific lifetime changes in NAD(P)H, in addi-
tion to the free/bound redox ratio association we have published
earlier.12
Our results demonstrate a delayed appearance and clearance
of fluorescein within the sinusoid of liver with I/R injury
(Fig. 5). Our mathematical model showed an increased elimina-
tion half-life and accumulation of fluorescein in the hepatocytes
in the I/R injury group compared to the sham group, although
only hepatocyte fluorescein accumulation was significantly
elevated (Fig. 7). The delayed uptake of fluorescein following
I/R injury is consistent with a previous study that showed
delayed uptake and clearance of indocyanine green (ICG) in
the rabbit liver following I/R injury.37 Another recent study
also found a reduced uptake and clearance of perfused rhod-
amine 123 in the rat liver after I/R injury.38 To our knowledge,
we are the first to use intravital imaging to visualize and model
the uptake and clearance of a fluorescent compound to assess
liver function following I/R injury.
Delayed ICG uptake by the rabbit liver after I/R injury was
associated with impaired hepatic microcirculation.37 In addition,
another study reports that I/R injury is associated with a reduc-
tion in sinusoid density within the liver,39 which is believed to
impair hepatic microcirculation.40 Therefore delayed fluorescein
uptake may be due to a decrease in sinusoid diameter that
impairs blood flow and thus availability of the dye to the
hepatocytes.
Interestingly, the differences in uptake and clearance of fluo-
rescein measured by intravital imaging were not observed in
plasma or bile using traditional HPLC to assay fluorescein or
fluorescein monoglucuronide (Fig. 8). However, the model of
I/R injury results in damage of parts of the liver, namely the
median and left lobes, leaving the remaining lobes intact. Thus,
the bile and plasma collected for concentration measurements
represent the whole liver, including the nonischemic lobes.
Intravital imaging allows us to image the damaged lobes directly
and record events in space and time in vivo.
In this study, we showed significantly decreased protein
expression of the MRP3 transporter at 4 h of reperfusion
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compared to the sham group (Fig. 9). As MRP3 is responsible
for transporting fluorescein from the hepatocytes into the
sinusoids, this result may explain the increased AUC accumu-
lation of fluorescein within the hepatocytes observed in
Fig. 7.
The expression of hepatic transporters is reported to be
altered as a result of I/R injury. For example, the expressions
of the bile salt export pump, MRP2, and OATP(s) were all
reported to be decreased after 24 h of reperfusion in rats,
while multidrug resistance protein 1B was increased.22–24 In
nonalcoholic fatty liver disease, expression of MRP2 has
been reported to be upregulated,41 whereas it was relatively
well preserved in cholestasis and primary biliary cirrhosis.42,43
Interestingly, mRNA and protein levels of the OATP2 trans-
porter appeared contradictory after 4 h of reperfusion [Fig. 7(a)
and 7(c)]. While the differences in OATP2 expression between
sham and I/R injury groups are not statistically significant, the
trend may suggest an initial upregulation of OATP2 expression,
as reflected by elevated protein levels after 4 h of reperfusion, to
augment impaired fluorescein uptake into the hepatocytes from
the sinusoids due to I/R damage. A consequence of increased
levels of transporters may be that they facilitate liver regenera-
tion and possibly increase bile secretion per weight of functional
liver and provide hepatic resistance against cytokine-metabolic
stress.44 Decreased mRNA transcripts of OATP2 in the I/R
injury group after 4 h may be indicative of a negative feedback
loop that has not yet affected protein levels at this time point.
The comparable mRNA and protein levels of OATP2 between
sham and I/R injury groups after 24 h appears to support this
hypothesis. Additional studies measuring changes in transcrip-
tion and protein levels real-time are necessary to elucidate this
possibility.
Our study has demonstrated that MPT imaging and the
kinetics of fluorescein uptake and/or clearance may be used
to measure liver function after transplantation, in order to assess
damage from I/R injury. This approach may be used to assess
liver damage intraoperatively by directly imaging selected lobes
of the transplanted or damaged liver.12 The advantage of this
approach is that potential damage could be determined in a
few hours, rather than up to 18 to 24 h post-transplantation
using plasma-ICG clearance,45 to allow for clinical intervention
prior to the completion of surgery. MPT imaging equipment and
the use of microendoscopic objectives are improving the size
and portability as demonstrated for dermatological imaging46
and small animal surgery,47 suggesting current equipment can
be used for assessing liver function in vivo as demonstrated
by our study.
In conclusion, intravital MPT is a simple and effective optical
technique to study drug distribution in normal and diseased
liver. It has proven to be a more sensitive alternative to bile
and plasma concentration measurements. Furthermore, we
have provided a simple mathematical model in studying drug
uptake and excretion using intravital MPT.
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